Recent News

• 04.25.2025 - PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition
• 04.24.2025 - 8-K - Current report
• 04.24.2025 - Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
• 04.24.2025 - Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
• 04.23.2025 - 8-K - Current report
• 04.16.2025 - Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
• 04.16.2025 - Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
• 04.08.2025 - 8-K - Current report
• 04.01.2025 - 8-K - Current report
• 03.31.2025 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Recent Filings

• 04.25.2025 - PRE 14A Other preliminary proxy statements
• 04.24.2025 - 8-K Current report
• 04.24.2025 - EX-99.1 EX-99.1
• 04.23.2025 - 8-K Current report
• 04.08.2025 - 8-K Current report
• 04.01.2025 - 8-K Current report
• 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.31.2025 - 8-K Current report